Is Rocket Lab (RKLB) Undervalued As Its 20 Launch Deal Tests Long Term Demand?
Rocket Lab (RKLB) just signed its largest commercial Electron contract to date, a multi-year deal to fly 20 Synspective missions, giving investors fresh data on long-term launch demand.
Rocket Lab’s shares at US$68.21 are down over the past week and year to date. However, the 1 month share price return of 8.4% and the very large 3 year total shareholder return indicate long term momentum, with some recent volatility as investors digest fresh contracts, Neutron progress and new analyst coverage.
Scan beyond Rocket Lab for other space and defense players with potential launch catalysts using our hand picked screener of 20 high quality undiscovered gems.
Rocket Lab now trades well below both analyst targets and one intrinsic value estimate, after a choppy stretch in the share price. The real tension is whether fair value lines up more closely with the models or the current market price.
Most Popular Narrative: 20% Undervalued
On the widely followed narrative, Rocket Lab screens as undervalued, with a fair value of $85.04 against the last close at $68.21. This perspective places more weight on future contracts and margin potential than the current share price does.
Neutron is the dominant near-term risk. Another tank failure, a launch anomaly, or further slippage into 2027 would not only delay the launch revenue ramp but also likely trigger multiple compression as the bull thesis loses its anchor. The market has already partially priced this risk in via the 25% drawdown from January's $99.58 high.
See why 113 investors see Rocket Lab as 20% undervalued.
Result: Fair Value of $85.04 (UNDERVALUED)
Still, the whole Rocket Lab narrative can crack quickly if Neutron suffers further setbacks, or if large defense customers slow contract conversion or awards.
Find out about the key risks to this Rocket Lab narrative.
Next Steps
Mixed about the Rocket Lab story after all this. Act while the data and sentiment are fresh, and stress test both sides of the argument with the 2 key rewards and 2 important warning signs.
Looking for more Rocket Lab investment ideas?
Do not stop your research at Rocket Lab alone. Broaden your watchlist now with focused ideas that could sharpen your next move.
- Target resilient income streams by scanning companies that feature 8 dividend fortresses for investors who want yield with substance.
- Zero in on potential mispricings by running through 29 high quality undervalued stocks and compare where the market price diverges from fundamentals.
- Add a safety buffer to your portfolio by filtering for 31 resilient stocks with low risk scores before the crowd starts paying attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com